Immunocore Holdings plc
IMCRFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Immunocore Holdings plc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 5 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 28, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| BESSEMER GROUP INC | 2026-03-31 | 46 | Not shown | SEC filing |
| CVA Family Office, LLC | 2026-03-31 | 32 | $965 | SEC filing |
| Entropy Technologies, LP | 2026-03-31 | 10,020 | $302K | SEC filing |
| JTC Employer Solutions Trustee Ltd | 2026-03-31 | 2,658 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 42,882 | $1.29M | SEC filing |
| SIMPLEX TRADING, LLC | 2026-03-31 | 1,451 | $43.7K | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 42 | $1.27K | SEC filing |
| Aberdeen Group plc | 2026-03-31 | 116,857 | $3.52M | SEC filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-03-31 | 4,706,168 | $142M | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 8,622 | $260K | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 100 | $3.02K | SEC filing |
| T. Rowe Price Investment Management, Inc. | 2026-03-31 | 1,891,600 | Not shown | SEC filing |
| Trexquant Investment LP | 2026-03-31 | 20,685 | $624K | SEC filing |
| Elmind Capital, LP | 2026-03-31 | 58,248 | $1.76M | SEC filing |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2026-03-31 | 94,936 | $2.86M | SEC filing |
| HRT FINANCIAL LP | 2026-03-31 | 22,861 | Not shown | SEC filing |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 2026-03-31 | 42,920 | $1.26M | SEC filing |
| Federation des caisses Desjardins du Quebec | 2026-03-31 | 8,312 | $251K | SEC filing |
| Hennion & Walsh Asset Management, Inc. | 2026-03-31 | 47,127 | $1.42M | SEC filing |
| Frazier Life Sciences Management, L.P. | 2026-03-31 | 484,782 | $14.6M | SEC filing |
- Each value is checked against Immunocore Holdings plc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 3 rows: the filed value is about 1,000 times too small for the share count at Immunocore Holdings plc's share price.
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Immunocore Holdings plc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-12-04 · Berman David M: Larger than 27 of the 29 other insider sales of Ordinary Shares on file. SEC filing
- 2025-11-26 · Berman David M: Larger than all 29 other insider sales of Ordinary Shares on file. SEC filing
- 2025-09-30 · Berman David M: Larger than 28 of the 29 other insider sales of Ordinary Shares on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-18 | Jallal Bahija · CHIEF EXECUTIVE OFFICER | Ordinary Shares | S — Open market or private sale | −11,474 | 32.35 | SEC filing |
| 2026-02-18 | GOLL JOHN · SVP, FINANCE & CAO | Ordinary Shares | S — Open market or private sale | −698 | 32.35 | SEC filing |
| 2026-02-18 | St Leger Tina Amber · CHIEF HR OFFICER | Ordinary Shares | S — Open market or private sale | −1,000 | 32.35 | SEC filing |
| 2026-02-18 | Berman David M · HEAD OF R&D | Ordinary Shares | S — Open market or private sale | −5,965 | 32.35 | SEC filing |
| 2025-12-05 | Berman David M · HEAD OF R&D | Ordinary Shares | S — Open market or private sale | −572 | 40.14 | SEC filing |
| 2025-12-04 | Berman David M · HEAD OF R&D | Ordinary Shares | S — Open market or private sale | −31,341 | 40.26 | SEC filing |
| 2025-11-28 | Berman David M · HEAD OF R&D | Ordinary Shares | S — Open market or private sale | −5,521 | 40.09 | SEC filing |
| 2025-11-26 | Berman David M · HEAD OF R&D | Ordinary Shares | S — Open market or private sale | −69,404 | 40.12 | SEC filing |
Showing 8 of 14 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-27 | Bell John Irving · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +27,492 | SEC filing |
| 2026-05-27 | Pao William · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +27,492 | SEC filing |
| 2026-05-27 | Herbst Roy Steven · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +27,492 | SEC filing |
| 2026-05-27 | Ratcliffe Peter John · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +27,492 | SEC filing |
| 2026-05-27 | Peterson Kristine · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +27,492 | SEC filing |
| 2026-05-27 | Kaul Siddharth · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +27,492 | SEC filing |
| 2026-02-17 | St Leger Tina Amber · CHIEF HR OFFICER | Ordinary Shares | M — Exercise or conversion of derivative security | +2,119 | SEC filing |
| 2026-02-17 | GOLL JOHN · SVP, FINANCE & CAO | Restricted Share Units | M — Exercise or conversion of derivative security | −1,351 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.